Health
A SARS-CoV-2 neutralizing antibody with extensive spike binding coverage – News-Medical.Net
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe…
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
The structural and functional characterization of the antibody reveals that it covers most of the receptor-binding motif of the spike receptor-binding domain (RBD) and is highly potent in completely…
-
Business15 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News15 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News15 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business19 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?